2025 年基准:了解 IVD 使用者体验
市场调查报告书
商品编码
1786120

2025 年基准:了解 IVD 使用者体验

Benchmarking for 2025: Understanding the IVD User Experience

出版日期: | 出版商: Kalorama Information | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

本报告展示了一项针对临床诊断专业人员的全面、多年调查(2019、2020、2022 和 2025 年)的结果,重点关注他们与供应商的合作体验、产品使用情况、购买行为和运营课题。这些调查结果提供了切实可行的见解,以加强客户参与度、支持产品创新并改善整个 IVD 行业的服务交付。这些见解涵盖了关键的临床诊断领域,包括临床化学、分子诊断和微生物学。

本报表包含一个 Tableau 工作簿,可协助您:

  • 揭示并比较领先供应商的单年和多年客户体验表现。
  • 探讨 2019 年及以后依接触点划分的趋势。
  • 深入了解不同地区、床位规模、细分市场、工作角色和年龄层的顾客满意度推动因素。

Tableau 工作簿完全互动式,可汇出图表用于示范、进一步研究或其他需求。这使您能够对客户进行基准测试,显示公司业绩,或将其与竞争对手进行比较。如有需要,可提供此工作簿的使用教学课程。

本报告为供应商提供在 IVD 市场中取得优势所需的洞察。了解客户体验有助于供应商加强与现有客户的关係并建立新客户。

2025 年版简要概述了人们对 IVD 供应商的当前看法,并重点关注以下目标:

  • 使临床诊断供应商能够在整个客户购买生命週期内将其客户体验与竞争对手进行基准测试。
  • 了解每个供应商在客户购买生命週期中每个接触点的相对优势和劣势。
  • 确定每个接触点在顾客购买生命週期中的相对重要性。
  • 评估实验室目前如何使用人工智慧,以及哪些应用最有益。
  • 评估关税和人员短缺如何影响实验室运作。

Kalorama Information and Bioinformatics 设计了一个线上定量调查,以实现这些目标。

  • 本报告共收集了 229 位受访者。
  • 这项调查是纵向调查,涵盖了过去六年,并在 2019 年、2020 年、2022 年和 2025 年进行了多次调查。
  • 调查包含 57 个问题(包括人口统计),平均回应时间约 20 分钟。

目录

top line报告

  • 摘要
  • 主要发现
  • 人口统计概览
  • IVD 供应商排名
  • 实验室在 AI、关税和人员短缺方面的经验
  • Tableau 使用者体验
  • 方法论与人口统计
  • 关于研究公司

Tableau工作簿

  • 1a. 客户概况
  • 2a. 顾客体验
  • 3a. 顾客体验趋势
  • 4a. 接触点绩效
  • 5a. 象限分析
  • 6a. COVID-19 影响
  • 6b. COVID-19 支持
  • 7a. 职业、年龄和地区
  • 7b.角色与职责
  • 7c. 产品订购
  • 7d. 已进行的测试
  • 7e. 合规性
  • 7f. 组织类型与规模
  • 7g. GPO
  • 7h. 供应商和已进行的测试
  • 7j. 供应商使用情况与特征
  • 8a. 概述
  • 8b. 顾客体验模型
  • 8c. 象限分析
  • 8d. 桑基图
  • 8e. 关于研究公司

*附註2019-2025 Tableau 工作簿中的大多数仪表板都提供了趋势图。

2025年简介被做的企业

  • Abbott
  • Agilent
  • ALPCO Diagnostics
  • Asuragen
  • AutoGenomics
  • BD Biosciences
  • Beckman Coulter
  • BioFire
  • Bio-Rad
  • Bruker
  • Cepheid
  • DiaSorin
  • EKF Diagnostics
  • ERBA Diagnostics
  • GenMark Diagnostics
  • Illumina
  • Meridian
  • Miltenyi Biotec
  • QuidelOrtho
  • Panasonic
  • Revvity
  • QIAGEN
  • Randox
  • Roche
  • SCIEX
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Tosoh
  • Werfen
简介目录
Product Code: 25-039KA

This report presents findings from a comprehensive survey of clinical diagnostics professionals, across multiple years (2019, 2020, 2022, and 2025), focusing on their experiences with vendors, product usage, purchasing behavior, and operational challenges. The findings offer actionable insights to enhance customer engagement, support product innovation, and improve service delivery across the IVD industry. These insights span key areas of clinical diagnostics, including clinical chemistry, molecular diagnostics, and microbiology.

The report includes a Tableau workbook which will allow you to:

  • Uncover and compare single and multi-year customer experience performances for leading vendors.
  • Explore touchpoint-specific trends since 2019.
  • Gain insights into customer satisfaction drivers across different regions, bed sizes, market segments, job positions, and age.

The Tableau workbook is fully interactive, and can be used to export charts for presentations, further research, or other needs. This will allow you to target your benchmarking to your customer, showcase your company's performance, or compare against competitors. Our team can provide tutorials for navigating this workbook upon request.

This report equips vendors with the insights needed to stay ahead in the IVD market. Understanding customer experience enables vendors to cultivate relationships with current customers and build relationships with new ones.

The 2025 edition is a snapshot of current perceptions towards IVD vendors and will focus on the following objectives:

  • Provide clinical diagnostics vendors with the ability to benchmark their customers' experiences against their competitors across the customer purchasing life cycle.
  • Identify the relative strengths and weaknesses of each vendor across touchpoints in the customer purchasing life cycle.
  • Determine the relative importance of each touchpoint in the customer purchasing life cycle.
  • Assess how labs are currently utilizing AI and which applications are most beneficial.
  • Evaluate how tariffs and staffing shortages have impacted lab operations.

Kalorama Information and Bioinformatics designed an online quantitative survey to address these objectives.

  • The survey this report was based on was fielded to n=229 respondents.
  • This study is longitudinal and trends over the course of the last six years, including waves from 2019, 2020, 2022 and 2025.
  • The survey contained 57 questions (including demographics) and took a median time of about 20 minutes to complete.

Table of Contents

Topline Report

  • Overview
  • Topline Findings
  • Demographics Overview
  • IVD Vendor Rankings
  • Laboratory Experiences with AI, Tariffs, and Staffing Shortages
  • Navigating Tableau
  • Methodology and Demographics
  • About Us

Tableau Workbook

  • 1a. Customer Profile
  • 2a. Customer Experience
  • 3a. Customer Experience Trended
  • 4a. Touchpoint Performance
  • 5a. Quadrant Analysis
  • 6a. COVID-19 Impact
  • 6b. COVID-19 Support
  • 7a. Job, Age, Region
  • 7b. Roles & Responsibilities
  • 7c. Ordering Products
  • 7d. Tests Performed
  • 7e. Compliance
  • 7f. Organization Type & Size
  • 7g. GPOs
  • 7h. Vendor and Tests Performed
  • 7j. Vendor Use & Characteristics
  • 8a. Overview
  • 8b. Customer Experience Model
  • 8c. Quadrant Analysis
  • 8d. Sankey Diagram
  • 8e. About Us

*Note: Trending is provided on most dashboards within the Tableau workbook for 2019-2025.

Companies Profiled in 2025

  • Abbott
  • Agilent
  • ALPCO Diagnostics
  • Asuragen
  • AutoGenomics
  • BD Biosciences
  • Beckman Coulter
  • BioFire
  • Bio-Rad
  • Bruker
  • Cepheid
  • DiaSorin
  • EKF Diagnostics
  • ERBA Diagnostics
  • GenMark Diagnostics
  • Illumina
  • Meridian
  • Miltenyi Biotec
  • QuidelOrtho
  • Panasonic
  • Revvity
  • QIAGEN
  • Randox
  • Roche
  • SCIEX
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Tosoh
  • Werfen